共 37 条
[1]
Bo JJ(2011)Androgen deprivation therapy through bilateral orchiectomy: increased metabolic risks Asian J Androl 13 833-837
[2]
Zhang C(2017)Adverse effects of androgen deprivation therapy in patients with prostate cancer: focus on metabolic complications Hormones 16 115-123
[3]
Zhang LH(2016)Influence of 1 year of androgen deprivation therapy on lipid and glucose metabolism and fat accumulation in Japanese patients with prostate cancer Prostate Cancer Prostatic Dis 19 57-62
[4]
Tzortzis V(2015)Quantifying the evidence for the risk of metabolic syndrome and its components following androgen deprivation therapy for prostate cancer: a meta-analysis PLOS One 20 10 e0117344-1134
[5]
Samarinas M(2014)GnRH antagonist associates with less adiposity and reduced characteristics of metabolic syndrome and atherosclerosis compared with orchiectomy and GnRH agonist in a preclinical mouse model Urol Oncol 32 1126-420
[6]
Zachos I(2015)FSH regulates fat accumulation and redistribution in aging through the Gαi/Ca Aging Cell 14 409-611
[7]
Mitsuzuka K(2019)/CREB pathway BJU Int 123 602-1628
[8]
Kyan A(2016)Metabolic consequences of gonadotropin-releasing hormone agonists vs orchiectomy: a randomized clinical study World J Urol 34 1621-E745
[9]
Sato T(1986)LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer Am J Physiol 250 E736-12
[10]
Bosco C(2012)Determination of total adipose tissue and body fat in women by computed tomography, 40 K, and tritium Indian J Endocrinol Metab 16 7-660